Esperion Therapeutics Stock (NASDAQ: ESPR) stock price, news, charts, stock research, profile.
Open | $1.780 |
Close | - |
Volume / Avg. | 4.537M / 6.679M |
Day Range | 1.710 - 1.920 |
52 Wk Range | 0.700 - 3.400 |
Market Cap | $340.921M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 10.55% |
Days to Cover | 2.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Esperion Therapeutics (NASDAQ: ESPR) through any online brokerage.
Other companies in Esperion Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH) and GH Research (NASDAQ:GHRS).
The latest price target for Esperion Therapeutics (NASDAQ: ESPR) was reported by Needham on Wednesday, April 10, 2024. The analyst firm set a price target for 8.00 expecting ESPR to rise to within 12 months (a possible 323.28% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Esperion Therapeutics (NASDAQ: ESPR) is $1.89 last updated Today at April 19, 2024 at 1:27 PM EDT.
There are no upcoming dividends for Esperion Therapeutics.
Esperion Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Esperion Therapeutics.
Esperion Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.